Categories: News

17-year-old Scientist Invents a $41 Smartwatch That Can Monitor and Treat Overdoses in Real-Time

SAN JOSE, Calif., April 28, 2021 /PRNewswire/ — Steve Dou, a California high school senior, has created a smartwatch to detect drug overdoses before they’re fatal. The device uses a complex system of biosensors built by Steve that can monitor a user’s body around the clock, detecting changes indicative of an overdose in measurements such as oxygen level, heart rate, and muscle movement—all without the need of a doctor.

Steve came up with the idea for his smartwatch at the age of 13 when he witnessed his brother suffer an opioid overdose that almost took his life. Determined to make a change, Steve cold-emailed numerous research groups, and when he was in ninth grade, a researcher at the University of Central Florida invited him to join a bioengineering lab. Steve has been working on the project for over three years now.

“Life-saving medications like naloxone are designed to rapidly reverse overdoses, but they won’t matter if nobody is nearby to administer them during an overdose,” says Milad Hamidi, Steve’s research supervisor at the University of Central Florida. “Steve’s invention, the Rescue Response Smartwatch, helps solve that problem by bringing an alarm system to the wrist of the user.”

If the user’s measurements were to pass a threshold, the smartwatch would automatically send an alert to 911. To establish the threshold measurements, Steve collaborated with the Orlando Regional Medical Center to obtain de-identified clinical datasets from overdose victims. The smartwatch’s intelligent machine learning algorithm was trained on this data. Unlike previous technologies, Steve’s smartwatch incorporates multiple biosensors and an onboard naloxone cartridge. The cartridge can be activated and used during an emergency to manage an overdose.

Steve has built dozens of copies of his Rescue Response Smartwatch, and he partnered with the North American Syringe Exchange Network to freely pass them out to homeless populations. This has been possible because each smartwatch only costs $41 to make, and Steve believes he could decrease it to as low as $22.

Aside from his smartwatch, Steve also invented Oncosentronic, a nanoparticle-based biosensor that can detect breast cancer cells in a patient’s blood samples to help with diagnoses. He hopes to create more medical technologies in the future, and currently, he is starting his very own biotechnology company, Medical Biosentronics, as its CTO. Steve’s work in biosensors has made him a Global Finalist in the Google Science Fair and a recipient of a $20,000 scholarship from the Coca-Cola Scholars Program.

Media Contact:
Steve Dou
408-658-7273
308231@email4pr.com 

View original content to download multimedia:http://www.prnewswire.com/news-releases/17-year-old-scientist-invents-a-41-smartwatch-that-can-monitor-and-treat-overdoses-in-real-time-301278905.html

SOURCE Steve Dou

Staff

Recent Posts

ONWARD® Medical Obtains Debt Financing with up to €52.5 Million Secured Loan from Runway Growth Capital LLC

THIS PRESS RELEASE CONTAINS INSIDE INFORMATION WITHIN THE MEANING OF ARTICLE (7)(1) OF THE EUROPEAN…

1 day ago

LSL Pharma Group Announces Voting Results of Its Annual and Special Meeting of Shareholders

BOUCHERVILLE, Québec, June 28, 2024 (GLOBE NEWSWIRE) -- LSL PHARMA GROUP INC. (TSXV: LSL, LSL.DB)…

1 day ago

Lowell Farms Inc. Announces Change of Chief Financial Officer

SALINAS, Calif., June 28, 2024 (GLOBE NEWSWIRE) -- Lowell Farms Inc. (the “Company”) (CSE: LOWL;…

1 day ago

PetVivo Reports Reports Fiscal 2024 Results

MINNEAPOLIS, MN, US, June 28, 2024 (GLOBE NEWSWIRE) -- PetVivo Holdings, Inc. (OTC: PETV, PETVW),…

1 day ago

Gain Therapeutics to Hold a Business Update Conference Call on July 1, 2024

BETHESDA, Md., June 28, 2024 (GLOBE NEWSWIRE) -- Gain Therapeutics, Inc. (Nasdaq: GANX) (“Gain”, or…

1 day ago

Cellectis Reports Results from Shareholders Meeting Held on June 28, 2024

NEW YORK, June 28, 2024 (GLOBE NEWSWIRE) -- Cellectis (Euronext Growth: ALCLS; Nasdaq: CLLS), a…

1 day ago